Chinese Colorectal Cancer Database
Launched by BEIJING FRIENDSHIP HOSPITAL · Jun 22, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Chinese Colorectal Cancer Database, aims to create a comprehensive collection of information about colorectal cancer patients in China. The goal is to understand how this disease affects people in China, including their symptoms, surgical outcomes, and any complications that may arise after surgery. By gathering this data, researchers hope to improve treatment methods and provide valuable insights for future studies on colorectal cancer.
To participate in this trial, you need to have a specific type of colon cancer called adenocarcinoma and be healthy enough to undergo surgery. It’s important that you understand what the trial involves and agree to take part by signing a consent form. If you join the study, you will help contribute to a database that can support healthcare decisions and academic research in the field of colorectal cancer. The trial is currently recruiting participants of all ages and genders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adenocarcinoma of the colon by biopsy
- • tolerable to surgery
- • be able to understand and willing to participate in this trial with signature
- Exclusion Criteria:
- • can not tolerate the surgery
- • history of serious mental illness
- • the researchers believe the patients should not enrolled in
About Beijing Friendship Hospital
Beijing Friendship Hospital, affiliated with Capital Medical University, is a leading comprehensive medical institution located in Beijing, China. Renowned for its advanced clinical services and cutting-edge research, the hospital plays a pivotal role in promoting healthcare innovation and improving patient outcomes. As a prominent clinical trial sponsor, Beijing Friendship Hospital is committed to conducting high-quality, ethical research that adheres to international standards. The hospital's multidisciplinary teams leverage their expertise across various medical fields to facilitate the development of new therapies and interventions, ultimately contributing to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials